Skip to main content
NCBI home page
Proceedings of the National Academy of Sciences of the United States of America logoLink to Proceedings of the National Academy of Sciences of the United States of America
. 1982 Jul;79(14):4420–4423. doi: 10.1073/pnas.79.14.4420

Effects of adrenal cortical steroids and osmotic blood-brain barrier opening on methotrexate delivery to gliomas in the rodent: the factor of the blood-brain barrier.

E A Neuwelt, P A Barnett, D D Bigner, E P Frenkel
PMCID: PMC346683  PMID: 6289301

Abstract

The effect of adrenal cortical steroids and osmotic blood-brain barrier modification on methotrexate delivery to normal and glioma-bearing rats was studied. In animals with the avian sarcoma virus-induced glioma, osmotic blood-brain barrier modification resulted in significantly increased delivery of methotrexate to the tumor-bearing hemisphere (including the tumor, the brain around the tumor, and the brain distant to the tumor), compared to the nonmodified hemisphere or to control animals. The administration of adrenal steroids, followed by intracarotid methotrexate, resulted in slightly decreased chemotherapeutic agent (methotrexate) delivery to the tumor, the brain around the tumor, and the brain distant to the tumor. When adrenal steroids were given prior to barrier modification and methotrexate therapy, the level of methotrexate was significantly less in the tumor. These studies provide evidence that the blood-brain barrier exists in tumors and is a factor in drug delivery to tumors. Steroid administration greatly interferes with the enhancement of drug delivery to tumors that can be achieved with osmotic blood-brain barrier modification.

Full text

PDF
4420

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Copeland D. D., Talley F. A., Bigner D. D. The fine structure of intracranial neoplasms induced by the inoculation of avian sarcoma virus in neonatal and adult rats. Am J Pathol. 1976 Apr;83(1):149–176. [PMC free article] [PubMed] [Google Scholar]
  2. Frei E., 3rd, Canellos G. P. Dose: a critical factor in cancer chemotherapy. Am J Med. 1980 Oct;69(4):585–594. doi: 10.1016/0002-9343(80)90472-6. [DOI] [PubMed] [Google Scholar]
  3. Geran R. I., Congleton G. F., Dudeck L. E., Abbott B. J., Gargus J. L. A mouse ependymoblastoma as an experimental model for screening potential antineoplastic drugs. Cancer Chemother Rep 2. 1974 Dec;4(4):53–87. [PubMed] [Google Scholar]
  4. Groothuis D. R., Fischer J. M., Lapin G., Bigner D. D., Vick N. A. Permeability of different experimental brain tumor models to horseradish peroxidase. J Neuropathol Exp Neurol. 1982 Mar;41(2):164–185. doi: 10.1097/00005072-198203000-00006. [DOI] [PubMed] [Google Scholar]
  5. Gutin P. H. Corticosteroid therapy in patients with cerebral tumors: benefits, mechanisms, problems, practicalities. Semin Oncol. 1975 Mar;2(1):49–56. [PubMed] [Google Scholar]
  6. Marty R., Cain M. L. Effects of corticosteroid (dexamethasone) administration on the brain scan. Radiology. 1973 Apr;107(1):117–121. doi: 10.1148/107.1.117. [DOI] [PubMed] [Google Scholar]
  7. Neuwelt E. A., Diehl J. T., Hill S. A., Maravilla K. R. Use of metrizamide computerized tomographic cisternography in the evaluation of patients with malignant glioma for immunotherapy. Neurosurgery. 1979 Nov;5(5):576–582. doi: 10.1227/00006123-197911000-00006. [DOI] [PubMed] [Google Scholar]
  8. Neuwelt E. A., Diehl J. T., Vu L. H., Hill S. A., Michael A. J., Frenkel E. P. Monitoring of methotrexate delivery in patients with malignant brain tumors after osmotic blood-brain barrier disruption. Ann Intern Med. 1981 Apr;94(4 Pt 1):449–454. doi: 10.7326/0003-4819-94-4-449. [DOI] [PubMed] [Google Scholar]
  9. Neuwelt E. A., Maravilla K. R., Frenkel E. P., Rapaport S. I., Hill S. A., Barnett P. A. Osmotic blood-brain barrier disruption. Computerized tomographic monitoring of chemotherapeutic agent delivery. J Clin Invest. 1979 Aug;64(2):684–688. doi: 10.1172/JCI109509. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Rapoport S. I., Fredericks W. R., Ohno K., Pettigrew K. D. Quantitative aspects of reversible osmotic opening of the blood-brain barrier. Am J Physiol. 1980 May;238(5):R421–R431. doi: 10.1152/ajpregu.1980.238.5.R421. [DOI] [PubMed] [Google Scholar]
  11. Rapoport S. I., Ohno K., Pettigrew K. D. Drug entry into the brain. Brain Res. 1979 Aug 24;172(2):354–359. doi: 10.1016/0006-8993(79)90546-8. [DOI] [PubMed] [Google Scholar]
  12. Vick N. A., Khandekar J. D., Bigner D. D. Chemotherapy of brain tumors. Arch Neurol. 1977 Sep;34(9):523–526. doi: 10.1001/archneur.1977.00500210025002. [DOI] [PubMed] [Google Scholar]

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

RESOURCES